Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020.
Saved in:
| Title: | Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020. |
|---|---|
| Authors: | Kalligeros M; Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island., Vassilopoulos A; Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island., Vassilopoulos S; Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island., Victor DW; Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Houston, Texas., Mylonakis E; Houston Methodist Hospital, Houston, Texas., Noureddin M; Houston Research Institute, Houston, Texas. Electronic address: noureddinmd@houstonresearchinstitute.com. |
| Source: | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Jun; Vol. 22 (6), pp. 1330-1332.e4. Date of Electronic Publication: 2023 Nov 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-7714 (Electronic) Linking ISSN: 15423565 NLM ISO Abbreviation: Clin Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1542-7714 |
|---|---|
| DOI: | 10.1016/j.cgh.2023.11.003 |
